Cargando…

Understanding and targeting centrally mediated visceral pain in inflammatory bowel disease

Detalles Bibliográficos
Autores principales:	Farrell, Kristen E., Callister, Robert J., Keely, Simon
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2014
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3942649/ https://www.ncbi.nlm.nih.gov/pubmed/24634658 http://dx.doi.org/10.3389/fphar.2014.00027

Ejemplares similares

Electroacupuncture Reduces Visceral Pain Via Cannabinoid CB2 Receptors in a Mouse Model of Inflammatory Bowel Disease
por: Zhang, Hong, et al.
Publicado: (2022)

Intestinal anti-inflammatory and visceral analgesic effects of a Serpylli herba extract in an experimental model of irritable bowel syndrome in rats
por: Ruiz-Malagón, Antonio Jesús, et al.
Publicado: (2022)

RIPK2 as a New Therapeutic Target in Inflammatory Bowel Diseases
por: Honjo, Hajime, et al.
Publicado: (2021)

Peroxisome Proliferator-Activated Receptors: Experimental Targeting for the Treatment of Inflammatory Bowel Diseases
por: Decara, Juan, et al.
Publicado: (2020)

Global research progress of visceral hypersensitivity and irritable bowel syndrome: bibliometrics and visualized analysis
por: Tian, Siyu, et al.
Publicado: (2023)

Precision Medicine in Inflammatory Bowel Diseases
por: Marafini, Irene, et al.
Publicado: (2021)

Research hotspots and trend analysis of abdominal pain in inflammatory bowel disease: a bibliometric and visualized analysis
por: Peng, Shuai, et al.
Publicado: (2023)

Farnesoid-X receptor as a therapeutic target for inflammatory bowel disease and colorectal cancer
por: Zhou, Mengjiao, et al.
Publicado: (2022)

Novel and Emerging Therapies for Inflammatory Bowel Disease
por: Al-Bawardy, Badr, et al.
Publicado: (2021)

Natural Anti-Inflammatory Compounds as Drug Candidates for Inflammatory Bowel Disease
por: Duan, Linshan, et al.
Publicado: (2021)

Gut-brain connections in neurodegenerative disease: immunotherapeutic targeting of Bin1 in inflammatory bowel disease and Alzheimer’s disease
por: Thomas, Sunil, et al.
Publicado: (2023)

Painful Understanding of VEGF
por: Llorián-Salvador, María, et al.
Publicado: (2018)

Cellular Mechanisms of Etrolizumab Treatment in Inflammatory Bowel Disease
por: Lichnog, Charlotte, et al.
Publicado: (2019)

Frontiers in Drug Research and Development for Inflammatory Bowel Disease
por: Currò, Diego, et al.
Publicado: (2017)

New Insights Into the Epigenetic Regulation of Inflammatory Bowel Disease
por: Xu, Jing, et al.
Publicado: (2022)

Deciphering the role of autophagy in the immunopathogenesis of inflammatory bowel disease
por: Li, Yue, et al.
Publicado: (2022)

Autophagy in intestinal fibrosis: relevance in inflammatory bowel disease
por: Macias-Ceja, Dulce C., et al.
Publicado: (2023)

The Effect of Serine Protease Inhibitors on Visceral Pain in Different Rodent Models With an Intestinal Insult
por: Ceuleers, Hannah, et al.
Publicado: (2022)

Therapeutic Effect of Amomum villosum on Inflammatory Bowel Disease in Rats
por: Chen, Zhu, et al.
Publicado: (2018)

Fecal Microbiota Transplantation for the Treatment of Inflammatory Bowel Disease: An Update
por: Tan, Pufang, et al.
Publicado: (2020)

The Placebo and Nocebo Responses in Clinical Trials in Inflammatory Bowel Diseases
por: Enck, Paul, et al.
Publicado: (2021)

Thiopurines: Recent Topics and Their Role in the Treatment of Inflammatory Bowel Diseases
por: Tominaga, Keiichi, et al.
Publicado: (2021)

Caspase-4 and -5 Biology in the Pathogenesis of Inflammatory Bowel Disease
por: Smith, Aoife P., et al.
Publicado: (2022)

Review of the Effects and Mechanism of Curcumin in the Treatment of Inflammatory Bowel Disease
por: Lin, Yuan, et al.
Publicado: (2022)

Hypoxia inducible factor prolyl hydroxylases in inflammatory bowel disease
por: Lun, Jie, et al.
Publicado: (2023)

Gut Microbiota Metabolism of Azathioprine: A New Hallmark for Personalized Drug-Targeted Therapy of Chronic Inflammatory Bowel Disease
por: Lazarević, Slavica, et al.
Publicado: (2022)

Targeting pathophysiological changes using biomaterials-based drug delivery systems: A key to managing inflammatory bowel disease
por: Mohajeri, Sahar, et al.
Publicado: (2022)

Daikenchuto attenuates visceral pain and suppresses eosinophil infiltration in inflammatory bowel disease in murine models
por: Kogure, Yoko, et al.
Publicado: (2020)

Antisense Oligonucleotide: Basic Concepts and Therapeutic Application in Inflammatory Bowel Disease
por: Di Fusco, Davide, et al.
Publicado: (2019)

Intestinal Macrophage Autophagy and its Pharmacological Application in Inflammatory Bowel Disease
por: Zheng, Yang, et al.
Publicado: (2021)

Role of Pyroptosis in Inflammatory Bowel Disease (IBD): From Gasdermins to DAMPs
por: Zhang, Shuxia, et al.
Publicado: (2022)

Medicinal plant-based drug delivery system for inflammatory bowel disease
por: Li, Ningcen, et al.
Publicado: (2023)

Inhibition of visceral nociceptors
por: Reed, David E., et al.
Publicado: (2014)

Targeting Cytokine Signaling and Lymphocyte Traffic via Small Molecules in Inflammatory Bowel Disease: JAK Inhibitors and S1PR Agonists
por: Pérez-Jeldres, Tamara, et al.
Publicado: (2019)

Plant-Derived Alkaloids: The Promising Disease-Modifying Agents for Inflammatory Bowel Disease
por: Peng, Jiao, et al.
Publicado: (2019)

Visceral hypersensitivity in inflammatory bowel diseases and irritable bowel syndrome: The role of proteases
por: Ceuleers, Hannah, et al.
Publicado: (2016)

Pharmacokinetic Differences of Wuji Pill Components in Normal and Chronic Visceral Hypersensitivity Irritable Bowel Syndrome Rats Attributable to Changes in Tight Junction and Transporters
por: Gong, Zipeng, et al.
Publicado: (2022)

Microbial-Based Therapies in the Treatment of Inflammatory Bowel Disease – An Overview of Human Studies
por: Basso, Paulo José, et al.
Publicado: (2019)

Activation of PXR by Alpinetin Contributes to Abrogate Chemically Induced Inflammatory Bowel Disease
por: Yu, Zhilun, et al.
Publicado: (2020)

An Update for Pharmacologists on New Treatment Options for Inflammatory Bowel Disease: The Clinicians’ Perspective
por: Schmidt, Carsten, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_i8lkdauoer3jh4rifm0ms8ebcd